GLR1.2 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction

The GLR1.2 antibody targets the GluR1 subunit of glutamate receptors, which are critical components of excitatory neurotransmission in the central nervous system . These receptors mediate the effects of L-glutamate, a primary excitatory neurotransmitter, by inducing conformational changes that open cation channels and convert chemical signals into electrical impulses . This article provides a detailed overview of the GLR1.2 antibody, including its function, related research findings, and potential applications.

General Information

The GLR1.2 antibody, also known as GluR1 Monoclonal Antibody (RH95), is a monoclonal antibody that recognizes the GluR1 protein . GluR1, or glutamate receptor 1, is an ionotropic glutamate receptor subunit that plays a key role in synaptic transmission . The antibody is available for research purposes but is not intended for diagnostic or therapeutic applications .

Aliases of GluR1 Protein :

  • GluA1

  • GluR-1

  • GluR-A

  • GluR-K1

Gene Aliases :

  • GRIA1

  • GLUR1

Function and Mechanism

GluR1 receptors are activated by L-glutamate, leading to a conformational change that opens cation channels . This process is fundamental for converting chemical signals into electrical impulses in neurons. Following activation, the receptor rapidly desensitizes and enters an inactive state while still bound to the agonist . The presence of proteins like CACNG4, CACNG7, or CACNG8 can cause resensitization, leading to a delayed accumulation of current flux with continued glutamate application .

Research Applications and Findings

The GLR1.2 antibody is utilized in various research applications to study the role of GluR1 receptors in different biological processes.

  • Trafficking Regulation: Research indicates that the AP2 complex regulates GLR-1 trafficking. AP2 mutations can affect the abundance of GLR-1 at synapses, suggesting a specific role for AP2 in promoting GLR-1 levels .

  • Endocytosis: GLR-1 endocytosis is influenced by AP2, as evidenced by studies involving apm-2 mutants. These mutants show decreased GLR-1::GFP puncta intensities, suggesting that AP2 functions upstream of UNC-11/AP180-dependent endocytosis of GLR-1 .

  • mRNA Levels: Studies have shown that glr-1 mRNA levels can increase in response to reductions in synaptic GLR-1, possibly indicating a feedback mechanism .

Utility in Drug Discovery

  • MRGPRX2 Agonists Screening: The GLR1.2 antibody has no direct role in MRGPRX2 studies, but other antibodies against GPCRs have been used to identify novel agonists . High-throughput screening (HTS) assays, coupled with mutagenesis, have identified compounds that selectively activate MRGPRX2, a receptor involved in pseudo-allergic drug reactions .

  • Functional GLP-1R Antibodies: While not directly related to GLR1.2, research into GLP-1R antibodies demonstrates the broader potential of antibody-based therapeutics targeting GPCRs . These antibodies can offer improved pharmacokinetic and pharmacodynamic profiles compared to traditional small molecules and peptides .

Data Tables

ExperimentObservationSignificance
AP2 Mutation in apm-2 MutantsReduction in GLR-1::GFP puncta intensities in the VNCIndicates that AP2 functions upstream of UNC-11/AP180-dependent endocytosis of GLR-1
apm-2; unc-11 Double MutantsSimilar reduction in GLR-1::GFP puncta intensities as in apm-2 single mutantsFurther supports that AP2 functions upstream of GLR-1 endocytosis
GLR-1(4KR)::GFP in apm-2 Mutants41% decrease in fluorescence puncta intensities in the VNC compared to wild-type controlsConfirms that AP2 functions upstream of GLR-1 endocytosis and postendocytic degradation
Real-time PCR in apm-2 Mutants2.3-fold increase in glr-1 mRNA compared to wild-type controlsSuggests a potential feedback mechanism where reductions in synaptic GLR-1 trigger increases in glr-1 transcription
HA::GLR-1::GFP in apm-2 Mutant Cell BodiesDecreased surface to total HA::GLR-1::GFP ratio (0.69 ± 0.04 compared to wild type: 1.0 ± 0.06, p < 0.001)Indicates that AP2 does not function in GLR-1 endocytosis at the cell body surface
MRGPRX2-N62S Mutant AssaySignificantly inhibited calcium response to substance P compared to the wild-type receptor (P<0.01)Confirms that the assay can be applied to HTS for detecting selective MRGPRX2 agonists. EC50 values were 160 ± 10 nM for WT and 283 ± 38 nM for N62S. Levels of protein expression were similar between WT and N62S. In empty HEK293-Gα15 cells without MRGPRX2, no increase in calcium response was detected compared to either the MRGPRX2-WT or the MRGPRX2-N62S cells .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
GLR1.2 antibody; At5g48400 antibody; MJE7.3Glutamate receptor 1.2 antibody; Ligand-gated ion channel 1.2 antibody
Target Names
GLR1.2
Uniprot No.

Target Background

Function
The GLR1.2 antibody targets a glutamate-gated receptor. This receptor likely functions as a non-selective cation channel and may play a role in light signal transduction and calcium homeostasis by regulating calcium influx into cells.
Database Links

KEGG: ath:AT5G48400

STRING: 3702.AT5G48400.2

UniGene: At.29852

Protein Families
Glutamate-gated ion channel (TC 1.A.10.1) family
Subcellular Location
Membrane; Multi-pass membrane protein.
Tissue Specificity
Expressed predominantly in roots and siliques.

Q&A

What is GLR1.2 and why is it significant in research?

GLR1.2 (Glutamate Receptor-Like 1.2) is a plant glutamate-like receptor that functions as a homolog of mammalian ionotropic glutamate receptors (iGluRs). In Arabidopsis, AtGLR1.2 plays critical roles in plant growth, development, and environmental stress responses. Research indicates that AtGLR1.2 positively enhances cold tolerance by activating endogenous jasmonate accumulation and subsequently promoting the downstream CBF/DREB1 cold response pathway during cold stress . Unlike their mammalian counterparts, plant GLRs function in non-excitable cells and have evolved specialized roles in plant signaling mechanisms.

What are the primary applications for GLR1.2 antibodies in research?

GLR1.2 antibodies serve multiple purposes in plant biology research:

ApplicationTypical Working DilutionKey Technical Considerations
Western blotting1:500-1:1000Protein extraction buffers should contain protease inhibitors to prevent degradation
Immunohistochemistry1:250-1:500Fixation method critically impacts epitope preservation
Immunoprecipitation1-5 μg per sampleMay require detergent optimization for membrane protein extraction
Immunocytochemistry1:500Cell permeabilization protocol affects antibody accessibility

When designing experiments with GLR1.2 antibodies, researchers should adopt validation approaches similar to those used for other glutamate receptor antibodies, including knockout validation to confirm specificity .

How should GLR1.2 antibodies be validated before experimental use?

Proper validation of GLR1.2 antibodies is essential for generating reliable results:

  • Knockout/knockdown validation: Test antibody reactivity in GLR1.2 knockout or knockdown plant lines. The antibody should show no signal in knockout tissue, confirming specificity .

  • Western blot analysis: Confirm the antibody detects a band of the expected molecular weight for GLR1.2 (~100 kDa based on similar glutamate receptors) .

  • Peptide competition assay: Pre-incubation of the antibody with the immunizing peptide should abolish specific signal.

  • Cross-reactivity testing: Evaluate potential cross-reactivity with other GLR family members, especially the closely related GLR1.3 .

  • Tissue expression pattern analysis: Verify that the antibody detects GLR1.2 in tissues known to express the protein based on transcript data.

What is the recommended protocol for immunoprecipitation of GLR1.2 from plant tissue samples?

Based on protocols used for other membrane-bound glutamate receptors, the following method is recommended for GLR1.2 immunoprecipitation:

  • Tissue preparation: Harvest plant tissue (roots, leaves, or other relevant tissues) and flash freeze in liquid nitrogen.

  • Protein extraction: Grind tissue to a fine powder and extract in a buffer containing 10 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, protease inhibitor cocktail, and phosphatase inhibitors .

  • Membrane protein solubilization: Incubate lysate for 30-60 minutes at 4°C with gentle rotation.

  • Pre-clearing: Incubate lysate with Protein A/G beads for 1 hour at 4°C to reduce nonspecific binding.

  • Immunoprecipitation: Add 2-5 μg of GLR1.2 antibody to pre-cleared lysate and incubate overnight at 4°C with gentle rotation.

  • Bead capture: Add pre-washed Protein A/G beads and incubate for 2-3 hours at 4°C.

  • Washing: Wash beads 3-5 times with extraction buffer containing reduced detergent concentration.

  • Elution: Elute proteins with SDS sample buffer for Western blot analysis or with a gentler elution buffer for downstream applications requiring native protein .

For studying protein-protein interactions, consider using a cross-linking agent prior to cell lysis to stabilize transient interactions .

How can I distinguish between GLR1.2 and GLR1.3 with antibodies given their sequence similarity?

Distinguishing between closely related GLR family members requires careful antibody selection and validation:

  • Epitope selection: Choose antibodies raised against unique regions of GLR1.2 that have minimal sequence homology with GLR1.3.

  • Competitive validation: Test antibody specificity by pre-absorbing with recombinant GLR1.3 protein to detect cross-reactivity.

  • Genetic validation: Include glr1.2 and glr1.3 single and double mutant controls in experiments to confirm signal specificity .

  • Sequential immunoprecipitation: Perform sequential immunoprecipitation with GLR1.3-specific antibodies first to deplete GLR1.3, followed by GLR1.2 immunoprecipitation.

  • Mass spectrometry verification: After immunoprecipitation, verify the identity of the pulled-down protein by mass spectrometry analysis .

What are effective strategies for using GLR1.2 antibodies to study protein-protein interactions in planta?

Several approaches can be employed to study GLR1.2 protein interactions:

  • Co-immunoprecipitation: Use GLR1.2 antibodies to pull down protein complexes, followed by Western blotting with antibodies against potential interacting partners .

  • Reversed immunoprecipitation: Immunoprecipitate with antibodies against suspected interaction partners and blot for GLR1.2 .

  • Proximity ligation assay (PLA): Use this technique to visualize protein-protein interactions in situ with <100 nm resolution.

  • Bimolecular fluorescence complementation (BiFC): While not antibody-based, this technique complements antibody approaches for studying protein interactions.

  • Blue native PAGE: This technique preserves protein complexes during electrophoresis and can be followed by immunoblotting with GLR1.2 antibodies to identify native complex sizes .

For example, to investigate potential interactions between GLR1.2 and GLR1.3, researchers might follow a protocol similar to that used for GLR3.2/GLR3.4 interactions , which revealed functional heteromeric channels in phloem that regulate lateral root development.

How can I troubleshoot low signal or high background issues with GLR1.2 antibodies?

IssuePotential CausesSolutions
Low or no signalInsufficient protein extractionOptimize protein extraction buffer; try different detergents for membrane proteins
Protein degradationUse fresh tissue; add protease inhibitors; keep samples cold
Epitope maskingTry different fixation methods; consider antigen retrieval methods
Insufficient antibody concentrationTitrate antibody; try longer incubation times
High backgroundNon-specific bindingIncrease blocking time/concentration; validate in knockout tissue
Secondary antibody issuesTry different secondary antibody; include additional blocking steps
Autofluorescence (in plant tissues)Use appropriate quenching methods; adjust imaging settings
Multiple bandsPost-translational modificationsVerify with phosphatase treatment for phosphorylation; use deglycosylation enzymes
Protein degradationAdd protease inhibitors; reduce sample processing time

For optimal results, each new lot of GLR1.2 antibody should be quality control tested by Western blot analysis on appropriate plant tissue lysates to confirm specific reactivity at the expected molecular weight .

What controls should be included when using GLR1.2 antibodies in experiments?

Essential controls for GLR1.2 antibody experiments include:

  • Negative genetic controls: Include samples from glr1.2 knockout/knockdown plants to confirm signal specificity .

  • Peptide competition controls: Pre-incubate antibody with immunizing peptide to demonstrate specific binding.

  • Secondary antibody-only controls: Omit primary antibody to identify nonspecific secondary antibody binding.

  • Positive tissue controls: Include tissues known to express high levels of GLR1.2 based on transcriptomic data.

  • Cross-reactivity controls: Test antibody against recombinant GLR1.3 and other related GLR proteins to evaluate specificity .

For co-immunoprecipitation experiments, implement IgG isotype controls and reverse the immunoprecipitation direction (IP with suspected interacting partner and blot for GLR1.2) .

How can I effectively use GLR1.2 antibodies to investigate cold stress responses in plants?

To study GLR1.2's role in cold stress responses:

  • Expression analysis: Use Western blotting with GLR1.2 antibodies to monitor protein expression changes during cold treatment time courses .

  • Tissue localization: Perform immunohistochemistry to visualize changes in GLR1.2 localization in different tissues during cold stress.

  • Protein-protein interactions: Use co-immunoprecipitation to identify changes in GLR1.2 interaction partners during cold stress conditions .

  • Phosphorylation status: Use phospho-specific antibodies or general phosphorylation detection methods after GLR1.2 immunoprecipitation to monitor post-translational modifications during stress.

  • Protein turnover: Combine cycloheximide treatment with Western blotting to assess GLR1.2 protein stability changes during cold stress.

Research has shown that GLR1.2 enhances cold tolerance by increasing endogenous jasmonate levels, which subsequently promotes the CBF/DREB1 cold response pathway . Antibodies can help elucidate the mechanism by which GLR1.2 protein mediates this signaling cascade.

What are the considerations for using GLR1.2 antibodies across different plant species?

When using GLR1.2 antibodies across different plant species, consider:

  • Sequence conservation: Verify epitope sequence conservation across target species using sequence alignment tools.

  • Validation in each species: Test antibody specificity in each new species before experimental use.

  • Optimization of protocols: Adjust extraction buffers, antibody concentrations, and incubation times for each species.

  • Positive controls: Include Arabidopsis samples as reference controls if using antibodies raised against Arabidopsis GLR1.2.

  • Western blot analysis: Confirm the detected molecular weight is consistent with predicted protein size in the new species.

For cross-species studies, antibodies generated against highly conserved domains will generally perform better than those targeting variable regions .

The methodologies used for studying glutamate receptors across species in mammalian systems can inform approaches for plant GLRs, while accounting for the unique characteristics of plant tissues .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.